Thursday, September 15, 2016

Nateglinide




In the US, Nateglinide (nateglinide systemic) is a member of the drug class meglitinides and is used to treat Diabetes, Type 2.

US matches:

  • Nateglinide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BX03

CAS registry number (Chemical Abstracts Service)

0105816-04-4

Chemical Formula

C19-H27-N-O3

Molecular Weight

317

Therapeutic Category

Oral antidiabetic agent, meglitinide (glinide)

Chemical Names

(-)-N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine (WHO)

D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, trans-

Foreign Names

  • Nateglinidum (Latin)
  • Nateglinid (German)
  • Natéglinide (French)
  • Nateglinida (Spanish)

Generic Names

  • Nateglinide (OS: USAN, BAN)
  • Natéglinide (OS: DCF)
  • A 4166 (IS)
  • AY 4166 (IS: Ajinomoto)
  • DJN 608 (IS)
  • Meglitinide (IS)
  • SDZ DJN 608 (IS: Sandoz)
  • Senaglinide (IS)
  • YM 026 (IS: Yamanouchi)

Brand Names

  • Fastic
    Ajinomoto, Japan; Daiichi Sankyo, Japan


  • Glinate
    Glenmark, India


  • Incuria
    Sanovel, Turkey


  • Nateglinide
    Dr. Reddy's, United States; Par, United States


  • Nopik
    Square, Bangladesh


  • Starform
    Novartis, Brazil


  • Starlix
    Bonafarma, Portugal; Novartis, Argentina; Novartis, Bangladesh; Novartis, Bulgaria; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Germany; Novartis, Spain; Novartis, Finland; Novartis, United Kingdom; Novartis, Georgia; Novartis, Greece; Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Luxembourg; Novartis, Malaysia; Novartis, Norway; Novartis, Oman; Novartis, Philippines; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, Venezuela; Novartis, South Africa; Novartis Pharmaceuticals, Peru


  • Starsis
    Astellas, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment